Biotechnology has shown tremendous progress in the developed countries. Several developing countries now have well-developed biotechnology programs; they are approaching the leading edge of biotechnology applications and have significant research capacity.
There is substantial variation among developing countries in terms of their capacity to develop and use biological products. Among all, some of the Asian countries try to consider biotechnology in their national priority list and Biotechnology is in the heart of their technology revolution. They have adopted strategies for harnessing the potential of biotechnology for their industrial development. The areas of applications both in pharmaceutical and agricultural sectors have widened, finding new horizons of economic growth.
We are proud to see that the Islamic Republic of Iran is achieved the 5th position among the Asian countries after Japan, South Korea, India and China. Iran has focused on both agricultural and medicinal applications of biotechnology, and has developed significant infrastructure both in terms of production and advanced methods.Indeed, the share of CinnaGen in this ranking position is something that can not be ignored as being a trustable producer for molecular biology reagents and recombinant biopharmaceuticals.
Since 1994, CinnaGen Co. has invested her resources in production of molecular biology reagents and related technologies that would meet the highest international standards. With such efforts, we have established processes to meet all quality criteria. R&D plays an important role in our policies for advancement. Using our expertise,we are constantly moving towards new products as well as improving the quality of our existing product lines.
With dedication of our experts and collaboration with other research centers, we have expanded our product list to more than 10 biopharmaceutical products.Our product list is a reflection of some of the most strategic needs of pharmaceutical markets in the region, and it is just the first steps toward development of new chemical entities in to the market.